Themes

Cancer and Blood Diseases

The Monash Partners Comprehensive Cancer Consortium (MPCCC) is the Cancer and Blood Diseases Theme. MPCCC is a strategic alliance of health service and research organisations working in partnership to improve outcomes for people affected by cancer. Our partners work collaboratively to bring a coordinated, multidisciplinary approach to innovating clinical oncology practices, improving cancer services and delivering the next generation of research for better cancer prevention, early detection and treatment of cancer.

Our goal is to improve patient experience and outcomes across the cancer care continuum, through world-class research and quality improvement.

This ambition will be realised by linking our expertise across basic translational, clinical, health service, population health and epidemiological research with the service delivery expertise of our clinical partners.

You can find out more about Monash Partners Comprehensive Cancer Consortium work here or follow MPCCC on Twitter and LinkedIn .

News and Resources

Message from the new Executive Director Professor Carol Hodgson Welcome to 2024, and my first message as Executive Director. It is an absolute privilege to be in this role… more
From the Director: End of year reflection As 2023 ends, Monash Partners would like to thank all we have worked with this year. Your support has ensured… more
2023 MIME Seed Funding results Congratulations to the seven successful project teams in the 2023 Monash Institute of Medical Engineering (MIME) Seed Funding round. A… more
From the Chair: Monash Partners Executive Director role Dear colleagues, On 14 January 2024, after more than 8 years of outstanding service to Monash Partners Academic Health Science Centre,… more

View all News & Resources